Maderazo Alan Baer 4
4 · GenMark Diagnostics, Inc. · Filed Jan 22, 2021
Insider Transaction Report
Form 4
Maderazo Alan Baer
VP, Qual, Reg, & Clin Affairs
Transactions
- Sale
Common Stock
2021-01-20$15.00/sh−5,000$75,000→ 225,899 total - Exercise/Conversion
Common Stock
2021-01-21+21,694→ 274,418 total - Exercise/Conversion
Common Stock
2021-01-21+16,666→ 291,084 total - Exercise/Conversion
Market Stock Units
2021-01-21−21,694→ 6,667 totalExercise: $0.00→ Common Stock (21,694 underlying) - Exercise/Conversion
Common Stock
2021-01-21+26,825→ 252,724 total - Exercise/Conversion
Market Stock Units
2021-01-21−26,825→ 0 totalExercise: $0.00→ Common Stock (26,825 underlying) - Exercise/Conversion
Market Stock Units
2021-01-21−16,666→ 16,667 totalExercise: $0.00→ Common Stock (16,666 underlying)
Footnotes (5)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by reporting person on 7/28/2020.
- [F2]The MSU's vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third performance periods, the Reporting Person was eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares on the Issuer's three-year total Shareholder return, as compared to the Nasdaq Composite Index.
- [F3]The MSU's vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares on the Issuer's two-year total Shareholder return, as compared to the Nasdaq Composite Index.
- [F4]Represents the target number of shares which remain subject to the award.
- [F5]The MSU's vest in three equal installments, on each of December 31, 2020, December 31, 2021, and December 31, 2022; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares on the Issuer's one-year total Shareholder return, as compared to the Nasdaq Composite Index.